Joint pain keeps returning, your scans look normal. Your genes may explain why.

Collagen type I is the workhorse protein in your bones, tendons, ligaments, and skin. It provides the structural framework that minerals like calcium bind to. Without strong collagen, even perfectly mineralized bone is mechanically weak. Think of it as the scaffolding that holds up a building. If the scaffolding is flawed, adding more concrete does not help.

The COL1A1 Sp1 site variant, carried by roughly 15 to 20 percent of people, impairs the cross-linking of collagen molecules. This means the collagen fibers do not bond to each other as tightly as they should. The result is a bone matrix that is structurally weaker and more prone to fracture, even when bone density numbers look normal on a scan.

You may notice that your injuries take longer to heal. Fractures from minor falls happen more easily than they should. Your joints may feel less stable, as if they are slightly loose in their sockets. Tendon and ligament injuries may recur in the same areas. These are all signs that your collagen architecture is running at a disadvantage.

Interleukin-6 is a signaling molecule that tells your immune system how aggressively to respond to injury or stress. It activates the RANKL pathway, which triggers osteoclasts (the cells that break down bone). In normal amounts, this is a healthy response. It cleans up old bone and makes room for new. But when your IL6 gene is set to a higher output, the inflammation signal stays elevated even after the initial stressor has resolved.

The IL6 C allele variant, present in roughly 40 percent of people, is associated with higher baseline IL-6 levels. This means your immune system responds more intensely to joint stress, driving faster bone breakdown and more aggressive cartilage inflammation. The signal does not turn off quickly.

You may experience joint swelling that lasts longer than it should. Your pain may be disproportionate to the activity that caused it. Morning stiffness may be pronounced. You may notice that anti-inflammatory foods or medications help, but only temporarily, because the underlying signal is genetically set higher. Rest does not seem to quiet the inflammation the way it does for others.

TNF-alpha is one of the most potent inflammatory signaling molecules your body produces. It coordinates the entire inflammatory response. In appropriate amounts, it protects you from infection and clears damaged tissue. But when your TNF gene produces too much, the inflammation becomes chronic and self-perpetuating. It activates osteoclasts aggressively and keeps them active longer than necessary.

The TNF A allele variant at position -308 (rs1800629), carried by roughly 30 percent of people, increases TNF-alpha production. People with this variant experience chronically elevated inflammatory tone in their joints, which accelerates bone loss and drives the formation of inflammatory arthritis. The inflammatory state becomes your baseline, not an exception.

You may experience joints that never quite feel calm. Even on good days, there is a low-level ache or stiffness. Flares can be triggered by foods, stress, sleep deprivation, or overactivity, but the underlying inflammation is always present. Your doctors may suspect rheumatoid arthritis or other inflammatory arthritis, but standard markers like rheumatoid factor might be negative. The TNF pathway can be driving joint inflammation without showing up clearly on routine bloodwork.

Your vitamin D receptor (VDR) is the gatekeeper for calcium absorption in your intestines and the activation of bone-building osteoblasts. Even if you have excellent vitamin D levels from sun exposure or supplementation, if your VDR is not functioning optimally, your body cannot absorb calcium or activate the mineral-dependent processes that mineralize bone. Think of VDR as the lock and vitamin D as the key. A faulty lock cannot be opened no matter how many keys you have.

The VDR BsmI, FokI, and TaqI variants are present in 30 to 50 percent of the population, depending on ancestry. These variants reduce the efficiency of the VDR protein, meaning you absorb calcium more poorly and activate osteoblasts less effectively, even when vitamin D status is adequate on lab tests. Your body is not translating nutritional mineral intake into bone mineralization.

You may have been told your vitamin D levels are fine, yet you still have low bone density. You may drink fortified milk and take calcium supplements and see minimal improvement in bone strength. You might notice that you bruise more easily or have slower injury recovery. You may have chronic muscle aches that do not respond to magnesium supplementation alone. These are signs that the problem is not intake but absorption and activation.

Collagen type XI is a structural component of cartilage, specifically the extracellular matrix that gives cartilage its resilience and shock-absorbing capacity. When your cartilage has strong type XI collagen, it can withstand compression, tension, and shear forces without tearing or degrading. When type XI collagen is weak or insufficient, cartilage becomes fragile and prone to early breakdown.

COL11A1 variants, present in roughly 20 to 30 percent of people, compromise the integrity of the cartilage matrix. This leads to accelerated cartilage loss, particularly in weight-bearing joints like the knees and hips, and is a strong risk factor for early-onset osteoarthritis. The damage can begin in your 40s or even earlier, even in people who are not overweight and who exercise regularly.

You may notice that your knee or hip pain is disproportionate to your activity level. Your cartilage loss may show up on imaging before age-related changes would be expected. You may have been told you have “the joints of someone ten years older.” You might experience joint hypermobility (joints that move too far) or instability alongside the pain. These are classic COL11A1 variant presentations.

GDF5 is a signaling molecule that controls how your joints are shaped during development and how quickly cartilage repairs itself after injury or wear. It tells your cartilage cells to divide and produce new matrix. When GDF5 signaling is strong, cartilage damage is repaired relatively quickly. When GDF5 is weak, the repair signal lags behind the damage signal, and cartilage loss accelerates.

The GDF5 rs143384 variant, present in roughly 40 percent of people, reduces the expression of the GDF5 protein. This means your joints have a slower intrinsic repair rate and are more susceptible to osteoarthritis, particularly in the knees and hips. You are essentially trying to maintain joints with a repair system that runs slower than normal.

You may notice that after an injury to a joint, recovery takes longer than expected. Pain and swelling persist weeks longer than they should. Repetitive activities that were previously fine begin to cause prolonged inflammation. You may develop osteoarthritis earlier than family history would suggest, or progress faster than typical once arthritis begins. Your joints simply do not bounce back the way they used to.